Advanced Enzyme Technologies share price
You have to be logged in to add this to Watchlist.- ₹372.75(-4.50%)May 12, 2026 14:37:04 PM IST
- NSE
- BSE
- Vol : 528.97 K (NSE + BSE)Last 20 day avg : 765.19 K
Advanced Enzyme Technologies is trading -4.50% lower at Rs 372.75 as compared to its last closing price. Advanced Enzyme Technologies has been trading in the price range of 393.70 & 372.55. Advanced Enzyme Technologies has given 29.16% in this year & 10.39% in the last 5 days. Advanced Enzyme Technologies has TTM P/E ratio 16.93 as compared to the sector P/E of 27.55.There are 1 analysts who have initiated coverage on Advanced Enzyme Technologies. There are 0.00 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 42.96 Crores in its last quarter.Listed peers of Advanced Enzyme Technologies include Cipla (-0.21%), Divi's Laboratories (-0.59%), Sun Pharmaceutical Industries (-0.76%).The Mutual Fund holding in Advanced Enzyme Technologies was at 1.93% in 31 Mar 2026. The MF holding has decreased from the last quarter. The FII holding in Advanced Enzyme Technologies was at 25.50% in 31 Mar 2026. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on May 12, 2026, 09:07 AM UTC
- BetaHigh volatility1.18Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.03The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.34Annual dividends as a percentage of the stock price.
- P/BLower than historical values2.79The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values26.29Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates overvaluation8.54The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Cipla | Bearish | 1,301.95 | -0.21 | 1,05,169.26 | 22.95 | 3.87 | 0.87 | 0.81 |
| Divi's Laboratories | Bullish | 6,674.50 | -0.59 | 1,76,806.49 | 78.61 | 11.52 | 0.46 | 0.01 |
| Sun Pharmaceutical Industries | Bullish | 1,858.10 | -0.76 | 4,45,809.93 | 36.24 | 5.77 | 0.92 | 0.50 |
| Dr Reddy's Laboratories | Neutral | 1,271.55 | -0.64 | 1,05,923.06 | 18.63 | 3.14 | 0.63 | 2.34 |
| Torrent Pharmaceuticals | Bullish | 4,403.85 | -2.55 | 1,49,269.86 | 67.32 | 17.1 | 0.83 | 17.62 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-05-09 | Audited Results & Dividend |
| 2026-01-31 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-02 | Quarterly Results |
| 2025-05-13 | Audited Results, Interim & Final Dividend |
- IndustryBiotechnology & Drugs
- ISININE837H01020
- BSE Code540025
- NSE CodeADVENZYMES
Advanced Enzyme Technologies is trading at 372.75 as on Tue May 12 2026 09:07:04. This is -4.50% lower as compared to its previous closing price of 390.30.
The market capitalization of Advanced Enzyme Technologies is 4172.07 Cr as on Tue May 12 2026 09:07:04.
The average broker rating on Advanced Enzyme Technologies is Buy. The breakup of analyst rating is given below -
- 0.00 analysts have given a strong buy rating
- 1 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Advanced Enzyme Technologies is 419.80 whereas the 52 wk low is 251.90
Advanced Enzyme Technologies can be analyzed on the following key metrics -
- TTM P/E: 16.93
- Sector P/E: 27.55
- Dividend Yield: 0.35%
- D/E ratio: 0.02
Advanced Enzyme Technologies reported a net profit of 168.72 Cr in 2026.
The Mutual Fund Shareholding was 1.93% at the end of 31 Mar 2026.
EQUITY QUICK LINKS
Advanced Enzyme Technologies QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.